skip to content
Home

Cambridge Cardiovascular

 

Cambridge University Hospitals Subscribe to RSS - Cambridge University Hospitals

Read more at: Dr Rouchelle Sriranjan Rothwell

Dr Rouchelle Sriranjan Rothwell

NIHR Clinical Lecturer in Cardiology (University of Cambridge)

Interventional Cardiology SpR (Royal Papworth Hospital)

Read more at: Dr Benn Jessney

Dr Benn Jessney

Clinical Research Associate / Cardiology Specialty Registrar

Read more at: Dr Lay Ping Ong

Dr Lay Ping Ong

Read more at: Elizabeth Le

Elizabeth Le

Read more at: Dr Tian Zhao

Dr Tian Zhao

Journal articles

2023

  • Zhao, TX. and Mallat, Z., 2023. Will gazing into the single-cell multiome illuminate cardiovascular drug development? Nat Cardiovasc Res, v. 2
    Doi: http://doi.org/10.1038/s44161-022-00209-3
    •

    2022

  • Zhao, TX., Aetesam-Ur-Rahman, M., Sage, AP., Victor, S., Kurian, R., Fielding, S., Ait-Oufella, H., Chiu, Y-D., Binder, CJ., Mckie, M., Hoole, SP. and Mallat, Z., 2022. Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study. Cardiovasc Res, v. 118
    Doi: http://doi.org/10.1093/cvr/cvab113
    •
  • Zhao, TX., Sriranjan, RS., Tuong, ZK., Lu, Y., Sage, AP., Nus, M., Hubsch, A., Kaloyirou, F., Vamvaka, E., Helmy, J., Kostapanos, M., Jalaludeen, N., Klatzmann, D., Tedgui, A., Rudd, JHF., Horton, SJ., Huntly, BJP., Hoole, SP., Bond, SP., Clatworthy, MR., Cheriyan, J. and Mallat, Z., 2022. Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease. NEJM Evid, v. 1
    Doi: 10.1056/EVIDoa2100009
    •
  • Zhao, TX., Sriranjan, RS., Tuong, ZK., Lu, Y., Sage, AP., Nus, M., Hubsch, A., Kaloyirou, F., Vamvaka, E., Helmy, J., Kostapanos, M., Jalaludeen, N., Klatzmann, D., Tedgui, A., Rudd, JHF., Horton, SJ., Huntly, BJP., Hoole, SP., Bond, SP., Clatworthy, MR., Cheriyan, J. and Mallat, Z., 2022. Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease NEJM Evidence, v. 1
    Doi: 10.1056/evidoa2100009
    •

    2021

  • Aetesam-Ur-Rahman, M., Giblett, JP., Khialani, B., Kyranis, S., Clarke, SJ., Zhao, TX., Braganza, DM., Clarke, SC., West, NEJ., Bennett, MR. and Hoole, SP., 2021. GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated. BMC Cardiovasc Disord, v. 21
    Doi: http://doi.org/10.1186/s12872-021-02030-5
    •
  • Yu, X., Newland, SA., Zhao, TX., Lu, Y., Sage, AS., Sun, Y., Sriranjan, RS., Ma, MKL., Lam, BYH., Nus, M., Harrison, JE., Bond, SJ., Cheng, X., Silvestre, J-S., Rudd, JHF., Cheriyan, J. and Mallat, Z., 2021. Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial Infarction. J Am Coll Cardiol, v. 78
    Doi: 10.1016/j.jacc.2021.07.018
    •
  • Aetesam-Ur-Rahman, M., Brown, AJ., Jaworski, C., Giblett, JP., Zhao, TX., Braganza, DM., Clarke, SC., Agrawal, BSK., Bennett, MR., West, NEJ. and Hoole, SP., 2021. Adenosine-Induced Coronary Steal Is Observed in Patients Presenting With ST-Segment-Elevation Myocardial Infarction. J Am Heart Assoc, v. 10
    Doi: http://doi.org/10.1161/JAHA.120.019899
    •

    2020

  • Zhao, TX., Newland, SA. and Mallat, Z., 2020. 2019 ATVB Plenary Lecture: Interleukin-2 Therapy in Cardiovascular Disease: The Potential to Regulate Innate and Adaptive Immunity. Arterioscler Thromb Vasc Biol, v. 40
    Doi: 10.1161/ATVBAHA.119.312287
    •
  • Nus, M., Basatemur, G., Galan, M., Cros-Brunsó, L., Zhao, TX., Masters, L., Harrison, J., Figg, N., Tsiantoulas, D., Geissmann, F., Binder, CJ., Sage, AP. and Mallat, Z., 2020. NR4A1 Deletion in Marginal Zone B Cells Exacerbates Atherosclerosis in Mice-Brief Report. Arterioscler Thromb Vasc Biol, v. 40
    Doi: 10.1161/ATVBAHA.120.314607
    •

    2019

  • Zhao, TX. and Mallat, Z., 2019. Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review. J Am Coll Cardiol, v. 73
    Doi: http://doi.org/10.1016/j.jacc.2018.12.083
    •
  • Giblett, JP., Clarke, S., Zhao, T., McCormick, LM., Braganza, DM., Densem, CG., O'Sullivan, M., Adlam, D., Clarke, SC., Steele, J., Fielding, S., West, NEJ., Villar, SS. and Hoole, SP., 2019. The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): A randomized, placebo-controlled trial American Heart Journal, v. 215
    Doi: http://doi.org/10.1016/j.ahj.2019.05.013
    •

    2018

  • Zhao, TX., Kostapanos, M., Griffiths, C., Arbon, EL., Hubsch, A., Kaloyirou, F., Helmy, J., Hoole, SP., Rudd, JHF., Wood, G., Burling, K., Bond, S., Cheriyan, J. and Mallat, Z., 2018. Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial. BMJ Open, v. 8
    Doi: 10.1136/bmjopen-2018-022452
    •
  • Clarke, SJ., Giblett, JP., Yang, LL., Hubsch, A., Zhao, T., Aetesam-Ur-Rahman, M., West, NEJ., O'Sullivan, M., Figg, N., Bennett, M., Wewer Albrechtsen, NJ., Deacon, CF., Cheriyan, J. and Hoole, SP., 2018. GLP-1 Is a Coronary Artery Vasodilator in Humans. J Am Heart Assoc, v. 7
    Doi: 10.1161/JAHA.118.010321
    •

    2011

  • Holtzman, T., Sivam, V., Zhao, T., Frey, O., van der Wal, PD., de Rooij, NF., Dalley, JW. and Edgley, SA., 2011. Multiple extra-synaptic spillover mechanisms regulate prolonged activity in cerebellar Golgi cell-granule cell loops. J Physiol, v. 589
    Doi: http://doi.org/10.1113/jphysiol.2011.207167
    •
    Theses / dissertations

    2020 (No publication date)

  • Zhao, TX., 2020 (No publication date). PHARMACOLOGICAL MODULATION OF THE ADAPTIVE IMMUNE SYSTEM IN ISCHAEMIC HEART DISEASE
    Doi: 10.17863/CAM.55391
    •
    Conference proceedings

    2020

  • Zhao, TX., Sriranjan, RS., Lu, Y., Hubsch, A., Kaloyirou, F., Vamvaka, E., Helmy, J., Kostapanos, M., Klatzmann, D., Tedgui, A., Rudd, JHF., Hooles, SP., Bond, SP., Maga, Z. and Cheriyan, J., 2020. Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS) EUROPEAN HEART JOURNAL, v. 41
    •

    2018

  • Hoole, SP., Clarke, S., Giblett, J., Aetesam-ur-Rahman, M., Zhao, T., West, N. and Cheriyan, J., 2018. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) HAS NO EFFECT ON PERIPHERAL VASODILATATION BUT AUGMENTS CORONARY MICROCIRCULATORY FLOW IN HUMANS JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, v. 71
    Doi: http://doi.org/10.1016/S0735-1097(18)30561-8
    •
  • Basatemur, G., Ackers-Johnson, M., Schoonejans, J., Kazachenka, A., Lam, B., Ma, M., Brimpari, M., Patel, M., Saleh, N., Murphy, D., Zhao, T., Yeo, G., Ferguson-Smith, A., Vallier, L., Sinha, S. and Mallat, Z., 2018. THE CHR9P21 RISK LOCUS AFFECTS IL-1/TLR SIGNALLING IN VSMC HEART, v. 104
    Doi: http://doi.org/10.1136/heartjnl-2018-BCS.128
    •
  • Aetesam-ur-Rahman, M., Zhao, T., Giblett, J., Braganza, D., Clarke, S., Bennett, M., West, N. and Hoole, S., 2018. Instability of Coronary Flow Velocity and Basal Microvascular Resistance does not Affect Reproducibility of iFR Post- PCI. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, v. 72
    Doi: http://doi.org/10.1016/j.jacc.2018.08.1634
    •
    Read more at: Dr Charis Costopoulos

    Dr Charis Costopoulos

    Read more at: Dr Mohammed M Chowdhury

    Dr Mohammed M Chowdhury

    Read more at: Dr Isuru Induruwa

    Dr Isuru Induruwa

    Read more at: Dr Michael Knapton

    Dr Michael Knapton

    Read more at: Professor Sadaf Farooqi

    Professor Sadaf Farooqi

    Cambridge Cardiovascular logo - transparent

    We connect cardiovascular researchers in Cambridge and beyond.

    For inquiries about our research, please contact Dr Jane Sugars

    For enquiries about our website or joining Cambridge Cardiovascular, please contact Denise Hatherly

    Find us on LinkedIn


     

    Our Newsletter


                 Subscribe here

            Previous Newsletters

    Find us on X

    Please follow us here on X for local news about research, events, funding calls, and open positions.

    You must be logged into X to see our feed here:

    Find us on YouTube

     

    Contact us

    Site Privacy & Cookie Policies

    Information provided by: 

    webmaster@cardiovascular.cam.ac.uk

    Cambridge Cardiovascular Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan

    Top Links

    External Links

    Study at Cambridge

    About the University

    Research at Cambridge